We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£148.21
It has never been this cheap. We have no record of a lower price.
£148 today · cheaper than every other day in the last 3 months
Springer Drug Resistance in Leukemia and Lymphoma III - Medical Reference
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 60 days · 60 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 60 days • 1 price levels
Price Analysis
Most common price: £148 (60 days, 100.0%)
Price range: £148 - £148
Price levels: 1 different prices over 60 days
Description
Key Features
Springer publication from the Advances in Experimental Medicine and Biology series, volume 457, providing peer-reviewed scientific content on oncology.
Proceedings from the 1998 International Symposium on Drug Resistance in Leukemia and Lymphoma held in Amsterdam, featuring expert presentations.
Comprehensive coverage of cellular drug resistance mechanisms and their clinical implications for leukaemia and lymphoma treatment.
Bridges laboratory research and clinical practice with contributions from leading oncologists and haematological specialists worldwide.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1461371805
- Domain
- Amazon UK
- Publication Date
- 05 November 2012
- Listed Since
- 03 March 2013
Barcode
No barcode data available
Similar Products You Might Like
Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)
Springer
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
CRC Press
Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1
Springer
Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
Springer
Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)
Elsevier
Treatment of Leukemia and Lymphoma Volume 51 - Medical Reference
Elsevier
Chemotherapy for Leukemia: Novel Drugs and Treatment
Springer
Frontiers in Leukemia Pharmacotherapy
Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)
Springer
Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)
Springer
Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects
Springer
Cancer Cell Chemoresistance And Chemosensitization
Scientific Publishing
Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)
Humana
Drug Resistance in Cancer Cells
Springer
Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects
Springer
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
Humana
Experimental Leukemia: History, Biology and Genetics Book
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Springer
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
Springer
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Springer
CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
Chronic and Acute Leukemias in Adults: 26 (Cancer Treatment and Research, 26)
Springer
New Agents for the Treatment of Acute Lymphoblastic Leukemia - Springer
Springer
Leukemias
Springer